| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.99 | $1.71 | $2.64 | $1.94 | $0.41 | $0.29 | $0.31 | $0.05 |
| EPS (Diluted) | $0.99 | $1.70 | $2.58 | $1.92 | $0.41 | $0.29 | $0.31 | $0.04 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.6B | $3.8B | $3.5B | $3.0B | $2.8B | $2.9B | $2.7B | $1.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $0.2B | $0.1B |
| Total Liabilities | $3.3B | $3.5B | $3.3B | $2.7B | $2.6B | $2.7B | $2.5B | $1.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | — | — |
| Investing Cash Flow | $0.2B | $-0.2B | $-0.8B | $-0.0B | $-0.3B | $0.1B | — | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.3B | $0.2B | $0.5B | $0.1B | $-0.1B | $0.2B | — | — |